Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer

OBJECTIVES: The effects of first-line chemotherapy on overall survival (OS) might be confounded by subsequent therapies in patients with small cell lung cancer (SCLC). We examined whether progression-free survival (PFS), post-progression survival (PPS), and tumor response could be valid surrogate en...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hisao, Mori, Keita, Wakuda, Kazushige, Ono, Akira, Akamatsu, Hiroaki, Shukuya, Takehito, Taira, Tetsuhiko, Kenmotsu, Hirotsugu, Naito, Tateaki, Kaira, Kyoichi, Murakami, Haruyasu, Endo, Masahiro, Nakajima, Takashi, Yamamoto, Nobuyuki, Takahashi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286848/
https://www.ncbi.nlm.nih.gov/pubmed/25593610
http://dx.doi.org/10.4103/1817-1737.146885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286848/
https://www.ncbi.nlm.nih.gov/pubmed/25593610
http://dx.doi.org/10.4103/1817-1737.146885

Ejemplares similares